IGC Pharma (IGC) Research & Development (2018 - 2025)
IGC Pharma (IGC) reported Research & Development of $1.6 million for Q3 2025, up 73.17% year-over-year from $917000.0 in Q3 2024, and up 86.6% quarter-over-quarter from $851000.0 in Q2 2025.
IGC Pharma (IGC) Research & Development (2018 - 2025) Analysis & Trends
IGC Pharma (IGC) has 8 years of Research & Development data on file, last reported at $1.6 million in Q3 2025.
- Research & Development for Q3 2025 came in at $1.6 million, up 73.17% year-over-year; the trailing twelve-month figure through Sep 2025 was $4.3 million (up 19.41% YoY), and the FY2026 annual result was $1.3 million, down 65.62% from the prior year.
- Research & Development advanced to $1.6 million in Q3 2025 per IGC's latest filing, from $851000.0 in the prior quarter.
- Over five years, Research & Development peaked at $1.6 million in Q3 2025 and troughed at $276000.0 in Q3 2021.
- A 5-year average of $843631.6 and a median of $852000.0 in 2024 frame the typical range for Research & Development.
- The sharpest annual moves came in 2022 and 2023: Research & Development jumped 304.26% in 2022, then tumbled 56.85% in 2023.
- A 5-year view of Research & Development shows it stood at $377000.0 in 2021, then jumped by 113.79% to $806000.0 in 2022, then increased by 12.03% to $903000.0 in 2023, then retreated by 5.65% to $852000.0 in 2024, then soared by 86.38% to $1.6 million in 2025.
- Business Quant data shows IGC's Research & Development at $1.6 million in Q3 2025, $851000.0 in Q2 2025, and $997000.0 in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | R&D (Qtr) |
|---|---|---|---|---|---|
| 1 | Alterity Therapeutics | 719,706.53 Bn | 719,706.50 Bn | - | 4.32 Mn |
| 2 | Belite Bio | 55,800.00 Bn | 55,800.00 Bn | - | 15.66 Mn |
| 3 | Quantum Biopharma | 18,182.30 Bn | 18,182.29 Bn | - | 626,092.00 |
| 4 | Legend Biotech | 3,154.00 Bn | 3,153.71 Bn | 242.10 Mn | -101.30 Mn |
| 5 | Akari Therapeutics | 1,844.30 Bn | 1,844.29 Bn | - | 1.46 Mn |
| 6 | Evaxion A | 1,567.96 Bn | 1,567.94 Bn | - | -2.30 Mn |
| 7 | Psyence Biomedical | 251.43 Bn | 251.42 Bn | - | 357,444.00 |
| 8 | Vertex Pharmaceuticals | 112.56 Bn | 105.31 Bn | 2.59 Bn | 961.60 Mn |
| 9 | Abivax | 94.37 Bn | 94.37 Bn | - | -58.00 Mn |
| 10 | IGC Pharma | 29.33 Mn | 29.07 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 1.59 Mn |
| Jun 30, 2025 | 851,000.00 |
| Mar 31, 2025 | 997,000.00 |
| Dec 31, 2024 | 852,000.00 |
| Sep 30, 2024 | 917,000.00 |
| Jun 30, 2024 | 889,000.00 |
| Mar 31, 2024 | 882,000.00 |
| Dec 31, 2023 | 903,000.00 |
| Sep 30, 2023 | 1.27 Mn |
| Jun 30, 2023 | 747,000.00 |
| Mar 31, 2023 | 532,000.00 |
| Dec 31, 2022 | 806,000.00 |
| Sep 30, 2022 | 768,000.00 |
| Jun 30, 2022 | 1.39 Mn |
| Mar 31, 2022 | 1.23 Mn |
| Dec 31, 2021 | 377,000.00 |
| Sep 30, 2021 | 276,000.00 |
| Jun 30, 2021 | 444,000.00 |
| Mar 31, 2021 | 305,000.00 |
| Dec 31, 2020 | 154,000.00 |